Overview

A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects

Status:
Terminated

Trial end date:
2010-06-04

Target enrollment:

Participant gender:

Summary

The purpose of this study in heathy people is to investigate the safety, toleration and time course of PF-03654764 in the blood, following multiple doses given by mouth together with fexofenadine.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Fexofenadine
Terfenadine